CBB Survey 2015
These data are submitted by the cord blood bank to the WMDA in February 2015. The WMDA makes no representations or express or implied warranties regarding any information on this site or obtained through these links; expressly disclaims all legal liability and responsibility for the accuracy, completeness, currency, suitability, validity, or usefulness of such information; and is not and will not be liable for any statements, errors, or omissions in posted information, or for any losses, injuries, or damages that arise or are alleged to arise from such information. Use of any information provided on this site does not and is not intended to create a contractual or other relationship. All information is on an as-is basis. The data cannot be updated.
(response ID 205)
| 1. General Information | ||||
|---|---|---|---|---|
| Name of CBB | CBB Basel | |||
| CBB Director | Dimitrios | |||
| CBB Director | Tsakiris | |||
| Address | Diagnostic Hematology | |||
| Address | University Hospital Basel | |||
| Address | Petersgraben 4 | |||
| Address | CH-4031 | |||
| Address | Basel | |||
| Phone Number | ||||
Website | ||||
| +41612652525 | ||||
| Date CBB Started Collecting Cord Blood Units (month/day/year) | 06/04/1997 | |||
| Number of Public Cord Blood Units | 2,966 | |||
| Planned Number of Public Cord Blood Units Stored in 2015 | 150 | |||
| Lists on BMDW | No | |||
| Affiliated with National Stem Cell Donor Registry | Yes | |||
| Registry Affiliation | Swiss Blood Stem Cell Registry | |||
| 2. Cord Blood Units in Inventory | ||||
| Current Processing Method | Current | Liquid+ red auto | ||
| Previous Processing Method | Liquid- red manual | |||
| Year Current Process Method Started | 2000 | |||
| Percent of Units Plasma and RBC Reduced (manual) | 4 | |||
| Percent of Units Plasma and RBC Reduced (automated) | Percent of Units No Volume Reduction | 96 | ||
| 3. Accreditations, Licenses and Certifications | ||||
| FACT-Netcord | No | |||
| AABB | No | |||
| Competent Authority/ National Health Authority | Yes | |||
| Name of Competent Authority | BAG | |||
| Audited by National Stem Cell Registry | Yes | |||
| ISO | Yes | |||
| Other | ISO17025 JACIE | |||
| 4. Cord Blood Collection | ||||
| Current Collection Practice Is the collection In/Ex -Utero or both? | Ex-utero | |||
| Current Antiseptic | Betadine | |||
| Collection Bag | Single needle | |||
| Agitation during Collection | Manual | |||
| 5. Conditioning/Transport from Collection Site to CBB | ||||
Transport Conditions | ||||
| Secondary Bag Used | Yes | |||
| Transport Conditions | ||||
Transport Conditions | ||||
Transport Conditions | ||||
| Ground transport | ||||
| Temp. for Storage and Transport | Temperature between +2 to +8°C | |||
| 6. Pre-Processing Evaluation | ||||
| Completed Prior to Accepting a CBU | ||||
Current Threshold for Accepting a CBU | ||||
Method for CD34 Remuneration | ||||
| Medical history, collection report, informed consent | ||||
| External Proficiency Testing for QC of FACS Lab | UKNEQAS | |||
| Post Processing/ Pre Freeze CD34+ Cell Count | Yes | |||
| Time from Collection to Processing | up to 48H | |||
| 7. Processing and Packaging | ||||
| Pre Freeze Processing Methods- Unit in Inventory | SEPAX | |||
| Pre Freeze Processing Methods- Unit in Inventory | Pre Freeze Processing Methods- Unit in Inventory | Volume reduction with HES-Manual | ||
| Pre Freeze Processing Methods- Current | SEPAX | |||
| Additives Currently in Use | HES | |||
| Current Cryopreservation Method | BioArchive | |||
| Current Cryoprotectant Additive | DMSO | |||
| Current Cryobag | Single bag (one fraction) | |||
| Current | CryobagCurrent | Target Cryopreservation Volume (mL) | 25.0 | |
| Current Packaging for Storage | Overwrap | |||
| Current Packaging for Storage | Canister | |||
| Current Packaging for Storage | ||||
Current Packaging for Storage | ||||
| More than one segment | ||||
| 8. Testing | ||||
| Extra Material Currently Stored | Cord blood DNA | |||
| Extra Material Currently Stored | Plasma/cord blood | |||
| Extra Material Currently Stored | Maternal DNA | |||
| Extra Material Currently Stored | ||||
Extra Material Currently Stored | ||||
Extra Material Currently Stored | ||||
| Maternal plasma/serum | ||||
| Current Post Processing Threshold for Accepting a CBU for Public Use TNC | 150 | |||
| Current Post Processing Threshold for Accepting a CBU for Public Use | TNCCD34 (10^6) Single Platform | NA | ||
| Current Post Processing Threshold for Accepting a CBU for Public Use CD34 (10^6) Double Platform | NA | |||
| Current Post Processing Threshold for Accepting a CBU for Public Use CFU-GM | NA | |||
| Current Post Processing Threshold for Accepting a CBU for Public Use CFU | NA | |||
| Current Post Processing Threshold for Accepting a CBU for Public Use Viability | NA | |||
| 9. Storage | ||||
| Type of Storage Container Used | ||||
Type of Storage Container Used | ||||
| BioArchive | ||||
| Monitoring of Storage | Centralized alarm system local | |||
| Monitoring of Storage | Centralized system remote monitoring | |||
| Monitoring of Storage | Monitoring of Storage | LN2 level | ||
| 10. HLA Typing | ||||
| Current Level of HLA Typing at Time of Listing HLA-A | IR | |||
| Current Level of HLA Typing at Time of Listing HLA-B | IR | |||
| Current Level of HLA Typing at Time of Listing HLA-C | ||||
| Current Level of HLA Typing at Time of Listing HLA-DRB1 | IR | |||
| Current Level of HLA Typing at Time of Listing HLA-DQB1 | ||||
| Current Level of HLA Typing at Time of Listing HLA-DPB1 | ||||
| Accreditation of HLA Lab | EFI accredited lab | |||
| Average Turnaround Time for Extended HLA Typing Results in days | 7 | |||
| Attached Segment Used for Confirmatory/ Verification Typing | No | |||
| Units Listed without Attached Segment and have not been Previously Typed on Attached Segment | No | |||
| Percentage of CBUs that have an Attached Segment | below 50% | |||
| Confirmatory/ Verification Typing on an Attached Segment is Pre-Release Requirement | No | |||
| 11. Reservation and Cancellation Policies | ||||
| What Point is a CBU Reserved for a Patient | HLA typing request | |||
| What Point is a CBU Reserved for a Patient | Reservation request | |||
| Length of Time a CBU can be Reserved in days | Other | |||
| Length of Time a CBU can be Reserved in days | not defined | |||
| Reservation Fee | Yes | |||
| Reservation Cancellation Fee in Absence of Shipment Request | No | |||
| Can Reservation be Extended | Yes | |||
| Is a Unit Report Provided on a Unit that is Reserved for Another Patient | No | |||
| Is TC Informed when CBU is Released | Yes | |||
| 12. Release and Shipment | ||||
| Hemoglobinopathy Screening Performed Prior to Release | Yes | |||
| Criteria to Ship a CBU Viability and Cell Count | NA | |||
| Criteria to Ship a CBU HLA Identity Testing | Yes | |||
| Current Packaging for Shipment to TC | Metal canister | |||
| Current Packaging for Shipment to TC | Overwrap | |||
| Current Packaging for Shipment to TC | 2 attached segments | |||
| Time Between Shipment Request and Sending CBU | 1-2 weeks | |||
| Fee for Shipment Cancellation | No | |||
| Dry Shippers Validated to Maintain Temperature of at least -150 for 48 hours Beyond Expected Arrival | Yes | |||
| Electronic Temperature Data Logger on All Dry Shippers | Yes | |||
| Who Selects Transport Company | Requesting transplant centre | |||
| Shape of Transport Container | Mushroom | |||
| 13. Adverse Events Reporting | ||||
| Who are S(P)EARS Reported To Competent Authority | Yes | |||
| Who are S(P)EARS Reported To | Internal ReportWho are S(P)EARS Reported ToNational Registry | Yes | ||
| Who are S(P)EARS Reported To Transplant Center | Who are S(P)EARS Reported To WMDA | Yes |
14. Pictures of cord blood units in the inventory
...
15. Infectious Disease Marker (IDM) CURRENTLY performed.
...
...
Attachments
| Attachments |
|---|
...
Holiday Calendar
| Team Calendars | ||
|---|---|---|
|